% | $
Quotes you view appear here for quick access.

Facebook, Inc. (FB) Message Board

  • biojax biojax Dec 5, 2013 2:39 PM Flag

    Make real money in 2014


    Here's a list of some potential catalysts, other than the top two for ATHX:

    ●End of enrollment for the ulcerative colitis trial

    ●Initiation of the GvHD phase II/III trial

    ●Initiation of the acute myocardial infarction phase II trial

    ●Realization of a partnership for the obesity drug

    ●Realization of a partnership for ischemic stroke

    ●Future grants or awards

    ●Potential milestone payments from RTI or Pfizer

    ●Legislation for Regenerative Medicine in Japan, may bring fast development path news.

    Now the real movers:

    The UC trial due at the end of the first quarter in 2014... easy pop to $7 on continuation to phase III * The phase III trial may be designed for crohn's disease.

    The IS trial due mid 2014... easy pop to $10 and that's being conservative with new laws in Japan. Phase III may not even be needed to market it in Japan.

    A holder of this stock asked that Athersys have an offering... Athersys did without a severe undercut of the share price. Couple this with the ability to draw down on the Aspire deal if needed and we have a bright future for Athersys ahead. Stroke is a slam dunk - follow the trials and Youtube video. The guy was healing faster than normal.

    Still not sure read:

    This topic is deleted.
94.26-0.61(-0.65%)Oct 12 4:00 PMEDT